High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 452 participants.

Also called NCT07059728

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 452 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07059728
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07059728. Randomized; no masking; primary purpose supportive care. Start 2027-01-01 (anticipated); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II
Condition
Aortic Stenosis Treated With TAVI
Condition
Sedation; Aged; Hemodynamics
Intervention (Device)
Oxygen therapy during sedation provided via high nasal cannulae (60L/min at 60% FiO2)
Intervention (Device)
Oxygen therapy during sedation delivered via nasal cannulae at 5L/min
Lead sponsor
Hospital Clinic of Barcelona (class: other)

Record details

Record id
cardio:ct-nct07059728
Content hash
722767c7be80ae862acc45323218cc06d1d7dd85a3b0effaeb98f5310e008532